Human hepatitis B virus enhancer 1 is responsive to human Interleukin-6

Journal of Medical Virology

Volumn 52, Issue 4, 1997, Pages 413-418

  Ohno, Hideki ^a   Kaneko, Shuichi ^a   Kobayashi, Kenichi ^a   Murakami, Seishi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Enhancer activity; HBV; HBx; IL 6; NF IL6

Indexed keywords

INTERLEUKIN 6; TRANSCRIPTION FACTOR;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENHANCER REGION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INFLAMMATION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA, VIRAL; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENES, REPORTER; GENES, VIRAL; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-6; MUTATION; NUCLEAR PROTEINS; PLASMIDS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 0030825362     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199708)52:4<413::AID-JMV12>3.0.CO;2-H     Document Type: Article

References (30)

1. Akira S, Kishimoto T (1992): IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25-50.
2. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990): A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Embo J 9(6): 1897-1906.
3. Andus T, Bauer J, Gerok W (1991): Effects of cytokines on the liver. Hepatology 13(2):364-375.
4. Aufiero B, Schneider RJ (1990): The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. Embo J 9(2):497-504.
5. Avantaggiati ML, Balsano C, Natoli G, De Marzio E, Will H, Elfassi E, Levrero M (1992): The hepatitis B virus X protein transactivation of c-fos and c-myc protooncogenes is mediated by multiple transcription factors. Arch Virol Suppl 4:57-61.
6. Benn J, Schneider RJ (1994): Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci of the USA 91(22): 10350-10354.
7. Bradford MM (1976): A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1993): The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67(3):1218-1226.
9. Devergne O, Peuchmaur M, Humbert M, Navratil E, Leger Ravet MB, Crevon MC, Petit MA, Galanaud P, Emilie D (1991): In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. Eur Cytokine Netw 2(3):183-194.
10. Dignam JD, Lebovitz RM, Roeder RG (1983): Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11(5):1475-1489.
11. Dikstein R, Faktor O, Ben Levy R, Shaul Y (1990): Functional organization of the hepatitis B virus enhancer. Mol Cell Biol 10(7): 3682-3689.
12. Faktor O, Budlovsky S, Ben LR, Shaul Y (1990): A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol 64(4):1861-1863.
13. Gorman CM, Moffat LF, Howard BH (1982): Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2(9):1044-1051.
14. Guo WT, Bell KD, Ou JH (1991): Characterization of the hepatitis B virus EnhI enhancer and X promoter complex. J Virol 65(12): 6686-6692.
15. Gutman A, Wasylyk C, Wasylyk B (1991): Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter. Mol Cell Biol 11(10):5381-5387.
16. Kakumu S, Fukatsu A, Shinagawa T, Kurokawa S, Kusakabe A (1992): Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease. J Clin Pathol 45(5):408-411.
17. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ito Y, Takayanagi M, Ida N (1991): Serum interleukin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol 86(12):1804-1808.
18. Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991): HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351(6324):317-320.
19. Kishimoto T, Taga T, Akira S (1994): Cytokine signal transduction. Cell 76(2):253-262.
20. Kodama K, Ogasawara N, Yoshikawa H, Murakami S (1985): Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol 56(3):978-986.
21. Lucito R, Schneider RJ (1992): Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66(2):983-991.
22. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S (1991): Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266(21):13759-13763.
23. Miller RH, Kaneko S, Chung CT, Girones R, Purcell RH (1989): Compact organization of the hepatitis B virus genome. Hepatology 9(2): 322-327.
24. Murakami S, Uchijima M, Shimoda A, Kaneko S, Kobayashi K, Hattori N (1990): Hepadnavirus enhancer and its binding proteins. Gastroenterol Jpn 25(Suppl 2):11-19.
25. Murakami S, Cheong J, Ohno S, Matsushima K, Kaneko S (1994a): Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 199(1):243-246.
26. Murakami S, Cheong JH, Kaneko S (1994b): Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269(21):15118-15123.
27. Seto E, Mitchell PJ, Yen TS (1990): Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344(6261):72-74.
28. Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H (1992): Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 12(3):197-200.
29. Torre D, Zeroli C, Giola M, Ferrario G, Fiori GP, Bonetta G, Tambini R (1994): Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 18(2):194-198.
30. Twu JS, Lai MY, Chen DS, Robinson WS (1993): Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192(1):346-350.